Singapore markets open in 8 hours 15 minutes

ABBV Jan 2026 175.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
19.05+0.44 (+2.36%)
As of 10:22AM EDT. Market open.
Full screen
Loading interactive chart…
  • Benzinga

    AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock

    Tuesday, AbbVie Inc (NYSE:ABBV) announced it received an FDA Complete Response Letter (CRL) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. In its letter, the FDA cited observations identified during the inspection of a third-party manufacturer listed in the New Drug Application (NDA). The inspection at the facility did not involve ABBV-951 or any AbbVie medicine. Also Read: AbbVie’s A

  • PR Newswire

    AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)

    AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson's disease.

  • Zacks

    Here's Why You Should Consider Buying Alvotech (ALVO) Stock

    Here, we discuss some reasons why buying Alvotech (ALVO) stock now may turn out to be a prudent move.